25 related articles for article (PubMed ID: 6815147)
1. Bursts in biosynthetic gene cluster transcription are accompanied by surges of natural compound production in the myxobacterium Sorangium sp.
Boldt J; Lukoševičiūtė L; Fu C; Steglich M; Bunk B; Junker V; Gollasch A; Trunkwalter B; Mohr KI; Beckstette M; Wink J; Overmann J; Müller R; Nübel U
Microb Biotechnol; 2023 May; 16(5):1054-1068. PubMed ID: 36998231
[TBL] [Abstract][Full Text] [Related]
2. The Predatory Myxobacterium
Zhou Y; Yi S; Zang Y; Yao Q; Zhu H
Microorganisms; 2021 Oct; 9(10):. PubMed ID: 34683458
[TBL] [Abstract][Full Text] [Related]
3. Microbial Pyrrolnitrin: Natural Metabolite with Immense Practical Utility.
Pawar S; Chaudhari A; Prabha R; Shukla R; Singh DP
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31484394
[TBL] [Abstract][Full Text] [Related]
4. Two new 2-alkylquinolones, inhibitory to the fish skin ulcer pathogen
Li D; Oku N; Hasada A; Shimizu M; Igarashi Y
Beilstein J Org Chem; 2018; 14():1446-1451. PubMed ID: 29977408
[TBL] [Abstract][Full Text] [Related]
5. Six Heterocyclic Metabolites from the Myxobacterium Labilithrix luteola.
Mulwa LS; Jansen R; Praditya DF; Mohr KI; Wink J; Steinmann E; Stadler M
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495640
[TBL] [Abstract][Full Text] [Related]
6. Gene Flow and Molecular Innovation in Bacteria.
Ruzzini AC; Clardy J
Curr Biol; 2016 Sep; 26(18):R859-R864. PubMed ID: 27676308
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical Potential of Synthetic and Natural Pyrrolomycins.
Cascioferro S; Raimondi MV; Cusimano MG; Raffa D; Maggio B; Daidone G; Schillaci D
Molecules; 2015 Dec; 20(12):21658-71. PubMed ID: 26690095
[TBL] [Abstract][Full Text] [Related]
8. Nitroaromatic compounds, from synthesis to biodegradation.
Ju KS; Parales RE
Microbiol Mol Biol Rev; 2010 Jun; 74(2):250-72. PubMed ID: 20508249
[TBL] [Abstract][Full Text] [Related]
9. Acetylcholinesterase-inhibiting activity of pyrrole derivatives from a novel marine gliding bacterium, Rapidithrix thailandica.
Sangnoi Y; Sakulkeo O; Yuenyongsawad S; Kanjana-opas A; Ingkaninan K; Plubrukarn A; Suwanborirux K
Mar Drugs; 2008; 6(4):578-86. PubMed ID: 19172195
[TBL] [Abstract][Full Text] [Related]
10. The second enzyme in pyrrolnitrin biosynthetic pathway is related to the heme-dependent dioxygenase superfamily.
De Laurentis W; Khim L; Anderson JL; Adam A; Johnson KA; Phillips RS; Chapman SK; van Pee KH; Naismith JH
Biochemistry; 2007 Oct; 46(43):12393-404. PubMed ID: 17924666
[TBL] [Abstract][Full Text] [Related]
11. Preliminary crystallographic characterization of PrnB, the second enzyme in the pyrrolnitrin biosynthetic pathway.
De Laurentis W; Leang K; Hahn K; Podemski B; Adam A; Kroschwald S; Carter LG; van Pee KH; Naismith JH
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Nov; 62(Pt 11):1134-7. PubMed ID: 17077497
[TBL] [Abstract][Full Text] [Related]
12. Novel oxidized derivatives of antifungal pyrrolnitrin from the bacterium Burkholderia cepacia K87.
Sultan Z; Park K; Lee SY; Park JK; Varughese T; Moon SS
J Antibiot (Tokyo); 2008 Jul; 61(7):420-5. PubMed ID: 18776654
[TBL] [Abstract][Full Text] [Related]
13. Bacteriocins from Myxococcus fulvus (Myxobacterales).
Hirsch HJ
Arch Microbiol; 1977 Oct; 115(1):45-9. PubMed ID: 412477
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of carotenoid synthesis in Myxococcus fulvus (Myxobacterales).
Kleinig H
Arch Microbiol; 1974 May; 97(3):217-26. PubMed ID: 4211208
[No Abstract] [Full Text] [Related]
15. Production, isolation, physico-chemical and biological properties of angiolam A, a new antibiotic from Angiococcus disciformis (Myxobacterales).
Kunze B; Kohl W; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1985 Dec; 38(12):1649-54. PubMed ID: 3937837
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolnitrin from Myxococcus fulvus (Myxobacterales).
Gerth K; Trowitzsch W; Wray V; Höfle G; Irschik H; Reichenbach H
J Antibiot (Tokyo); 1982 Aug; 35(8):1101-3. PubMed ID: 6815147
[No Abstract] [Full Text] [Related]
17. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties.
Gerth K; Irschik H; Reichenbach H; Trowitzsch W
J Antibiot (Tokyo); 1980 Dec; 33(12):1474-9. PubMed ID: 6788741
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
